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LETTERS TO THE EDITOR
Ischemic Preconditioning During
Coronary Angioplasty
Dupouy et al. (1) conclude that in patients undergoing percutaneous
transluminal coronary angioplasty (PTCA), three 120-s balloon inflations
do not induce preconditioning against myocardial ischemia. These data
are apparently in conflict with previous investigations by our group (2) and
others (3–7) that reported less ST segment shift and less anginal discom-
fort during successive balloon inflations in patients undergoing PTCA.
One reason for the failure of Dupouy et al. to detect a decrease in ST
segment elevation may be that they measured ST segment shifts only
during the first 90 s of balloon inflation. A previous study (3) showed that
at 90 s of balloon inflation, there was little difference in intracoronary ST
segment elevation between the first and third inflation, whereas at 120 s
there was a marked difference. Thus, evidence of preconditioning during
PTCA should not be expected to be consistently present when the ECG
is recorded for only 90 s. Indeed, evidence of preconditioning has been
found consistently in those studies that have recorded the ECG for 120 s
(2–5) but inconsistently in those studies that have recorded the ECG for
,120 s (1,6,7,8,9).
In the report by Dupouy et al. (1), intracoronary ST segment
elevation averaged ;0.15 mV (1.5 mm) at 90 s into the first balloon
inflation. This is in striking contrast with all previous investigations,
which have reported average values of intracoronary ST segment
elevation of 1.0 to 2.2 mV at 90 to 120 s during the first inflation
(2–5,10). Dupouy et al. also reported a 12-fold greater ST segment
shift on the surface electrocardiogram (ECG) (average: 1.8 mV during
first inflation) than on the intracoronary ECG. This is also in striking
contrast with all previous studies (2–5,7,10).
Dupouy et al. (1) point out that their results are consistent with two
previous studies (8,9) that failed to demonstrate any reduction in the ST
segment shift with successive balloon inflations. One of these studies (8)
used surface leads (which are less sensitive than intracoronary leads [10])
and only 60 s of coronary occlusion. In the other study (9), several brief
balloon inflations were performed before the control measurements, and
therefore the patients were probably preconditioned; furthermore, only
surface ECG leads were recorded and for a maximum period of 60 s.
The lack of improvement in septal wall thickening observed by
Dupouy et al. (1) during subsequent balloon inflations is predictable
(3). Experimental studies have clearly demonstrated that brief isch-
emic insults do not mitigate the changes in contractile performance
during subsequent ischemia, even when a preconditioning effect is
present (11). Similar considerations apply to the indexes of global
ventricular function; furthermore, these indexes are relatively insensi-
tive in detecting regional changes.
In conclusion, the results of Dupouy et al. (1) do not disprove the
occurrence of ischemic preconditioning during PTCA; rather, they
emphasize the importance of recording the ECG for at least 120 s
during each ischemic episode. These results also confirm that changes
in contractile performance during ischemia should not be relied on as
an index of protection.
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Reply
The purpose of our study (1) was clearly to evaluate whether myocar-
dial preconditioning could be evidenced during routine balloon coro-
nary angioplasty with a view to facilitating subsequent longer infla-
tions. We studied three consecutive 120-s balloon occlusions, and
maximal ST segment elevation occurred at 90 s (mean [6SD] 150 6
20 s), with no further change thereafter. Maximal ST segment eleva-
tion was not observed before 120 s in a previous study on the same
subject (2), but the study patients were quite different from ours
regarding collateral circulation, which was found in 30% of patients
before any inflation. This collateral circulation could have postponed
the maximal ST segment modification. Our patients did not have any
visible angiographic collateral vessels.
Systolic and diastolic function has been shown to be altered during
ischemia induced by balloon inflation (3), but to our knowledge there
were no data on the evolution of diastolic alterations after multiple
ischemic episodes in humans. We agree that the interpretation of
global left ventricular function is complex and is the result of local and
adjacent wall motion modifications (4); but one of the main goals of
our study was to show that there was no change in contraction and
relaxation modification by previous ischemia (1).
Bidimensional echocardiography is a well accepted technique for
studying segmental alterations during ischemia (5,6). It has been
shown (2) on angiographic ventriculography that repeat ischemia did
not modify the extent of involved myocardium, but direct data on the
local contractility were not available. In our patients, the septal wall
thickening was equally altered after three 120-s balloon inflations,
which indicates the absence of ischemic protection for myocardial
contractility.
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The definition of preconditioning has greatly changed from the first
description of the limitation of infarct size by previous short episodes
of ischemia (7,8) and has been extended to all adaptive processes after
myocardial ischemia. It was interesting to test whether local and global
variables of myocardial function were all equally affected by this
ischemic protection. In fact, we were unable to show any precondi-
tioning in this very selected patient group. This means that ischemic
adaptation is not a permanent phenomenon and that individual
susceptibility exists concerning this phenomenon.
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Bradycardia After Heart Transplantation:
Reversal With Theophylline
Bertolet et al. (1) are to be congratulated on their study on the reversal
of bradycardia after cardiac transplantation with theophylline. How-
ever, I want to make the following comments:
1. I feel that it is important to specifically delineate the origin of
the rhythm. The origin of the rhythm in the donor heart is an
important determinant of the magnitude of a chronotropic theophyl-
line effect. Evidence is accumulating, and most will agree (I do) that
theophylline is effective in ameliorating sinus bradycardia. In our
experience, xanthine derivatives are helpful as soon as sinus rhythm
has been established. However, I have not yet seen a patient going into
sinus rhythm from asystole or junctional bradycardia. In this context, it
would be interesting to know whether a greater percentage of patients
revert to sinus rhythm from initial junctional bradycardia with the use
of theophylline. Thus far, this has not been investigated in the
posttransplantation population. Was any such effect noted in the study
of Bertolet et al.? What was the rhythm in the three patients
unresponsive to theophylline who finally received a permanent pace-
maker? Were these patients not in sinus rhythm? This could provide
an explanation for the inadequate chronotropic effect.
2. Although I deem possible a specific (adenosine antagonistic)
effect of theophylline in posttransplantation sick sinus syndrome, I do
not believe that the data presented in the study of Bertolet et al.
support such a conclusion. When looking at Figure 2, there is an effect
of theophylline in control patients, albeit smaller. This can be suffi-
ciently explained by the supersensitivity of theophylline in the dener-
vated transplanted heart. It would have been more helpful to addi-
tionally study the effect of theophylline in the transplant recipients
without bradycardia. Moreover, there are numerous reports on the
effectiveness of theophylline in sick sinus syndrome in the native heart.
3. The type of atrial incision used was not specified in the report.
The wear and tear during harvesting of the donor organ and during the
implantation procedure and the associated trauma to the sinus node or
its blood supply, or both, are important etiologic factors. We found a
decline in pacemaker requirement and incidence of sinus node defi-
ciency over time, indicating the effect of a learning curve. This
probably was related to a more distal ligation of the superior caval
vein. In addition, our incidence further declined with the use of bicaval
anastomosis. This effect of the bicaval anastomosis technique has also
been observed by other centers.
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Reply
We thank Heinz for his comments regarding our report (1). We agree
with Heinz that the role of theophylline and similar adenosine
antagonists for the treatment of bradyarrhythmias is emerging. Brady-
arrhythmias associated with excessive endogenous adenosine-
mediated cardiac effects include sinus bradycardia, sinus node arrest,
various degrees of atrioventricular node blockade and perpetuation of
asystole. These arrhythmias become manifest in a variety of clinical
situations, such as acute myocardial infarction (2), sick sinus syndrome
(3–5), cardiac arrest (6,7) or heart transplant rejection (8,9), and seem
to be responsive to theophylline.
In particular, the transplanted denervated hearts exhibit increased
responsiveness to the negative dromotropic and chronotropic effects of
adenosine (10). The mechanism responsible for this increased sensi-
tivity remains to be determined. However, in the presence of clinically
significant sinoatrial node dysfunction in transplant recipients, we
know that antagonism of the adenosine A1 receptor will not only block
the direct effects of adenosine on the sinoatrial node, but also allow
circulating catecholamines to become more effective. Moreover, the-
ophylline, at the plasma concentrations measured in our study, is likely
to primarily act as an adenosine receptor antagonist, with little or no
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